The loss of AMPK signal transduction can enhance oncogenic drivers such as LKB1, TSC2, and P53, thereby promoting cell growth, proliferation, and the reprogramming of cancer cell metabolis [34, 35]. The gene discussed is STK11; the disease is cancer.